secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2026-02-03T23:59:59+00:00
Accession:  0001493152-26-004905
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics dismisses Baker Tilly, appoints CBIZ CPAs as new auditor
-----------------------------------------------------------------------------

- Baker Tilly dismissed as independent auditor effective January 31, 2026.
- CBIZ CPAs (formerly Mayer Hoffman McCann) appointed February 2, 2026.
- No disagreements with Baker Tilly on accounting principles or disclosures.
- Baker Tilly's prior reports included a going-concern explanatory paragraph.
- CBIZ CPAs previously served as Dermata's auditor from 2016 to 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/0001493152-26-004905-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000149315226004905/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004905

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer